APA (7th ed.) Citation

Suraweera, A., O’Byrne, K. J., & Richard, D. J. (2018). Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi. Frontiers in oncology, 8, 92. https://doi.org/10.3389/fonc.2018.00092

Chicago Style (17th ed.) Citation

Suraweera, Amila, Kenneth J. O’Byrne, and Derek J. Richard. "Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi." Frontiers in Oncology 8 (2018): 92. https://doi.org/10.3389/fonc.2018.00092.

MLA (9th ed.) Citation

Suraweera, Amila, et al. "Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi." Frontiers in Oncology, vol. 8, 2018, p. 92, https://doi.org/10.3389/fonc.2018.00092.